Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.45 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | HTR7 | P34969 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21796607 | 0.88 | CA12 (0.50) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL29385200 | 0.86 | TSHR (0.45) | CA12CA1CA2CA9HPGD | |
| SCHEMBL28586997 | 0.86 | TSHR (0.45) | CA12CA1CA2CA9HPGD | |
| SCHEMBL29703355 | 0.86 | TSHR (0.45) | CA12CA1CA2CA9HPGD | |
| SCHEMBL160151 | 0.86 | TSHR (0.45) | CA12CA1CA2CA9HPGD | |
| SCHEMBL29706107 | 0.86 | ESR2 (0.54) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL616 | 0.86 | ESR2 (0.54) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL5570618 | 0.86 | PDCD1 (0.47) | CA12CA1CA2CA9HPGD | |
| SCHEMBL42793 | 0.86 | PDCD1 (0.47) | CA12CA1CA2CA9HPGD | |
| SCHEMBL28817559 | 0.86 | PDCD1 (0.47) | CA12CA1CA2CA9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109734860-A | A kind of urethane composition for vacuum introducing technology | 四川东树新材料有限公司 | 2019-05-10 | — | — | CN | claimed |
| CN-105367604-B | Phosphorus-nitrogen-containing star-type charring agent and preparation method thereof | 太原理工大学 | 2017-04-12 | — | — | CN | claimed |
| JP-2007517115-A | — | — | 2007-06-28 | — | — | JP | claimed |
| EP-1701989-A2 | LOW K-FACTOR RIGID FOAM SYSTEMS | Bayer MaterialScience LLC (US) | 2006-09-20 | — | — | EP | claimed |
| WO-2005066233-A2 | LOW K-FACTOR RIGID FOAM SYSTEMS | BAYER MATERIALSCIENCE LLC (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050148677-A1 | Low K-factor rigid foam systems | BAYER MATERIALSCIENCE LLC | 2005-07-07 | — | — | US | claimed |
| CN-118339170-A | Silylated organomodified compounds | 迈图高新材料公司 | 2024-07-12 | — | — | CN | disclosed |
| EP-3880734-B1 | WATER PROCESSES FOR PRODUCING POLYETHER POLYOLS FROM SOLID POLYHYDROXYL COMPOUNDS | COVESTRO LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023096809-A1 | SILYLATED ORGANOMODIFIED COMPOUNDS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| US-20230159571-A1 | SILYLATED ORGANOMODIFIED COMPOUNDS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-25 | — | — | US | disclosed |
| US-11629225-B2 | Processes for producing aromatic diamine-initiated polyether polyols | COVESTRO LLC (US) | 2023-04-18 | — | — | US | disclosed |
| EP-4157914-A1 | PROCESSES FOR PRODUCING AROMATIC DIAMINE-INITIATED POLYETHER POLYOLS | Covestro Deutschland AG (DE) | 2023-04-05 | — | — | EP | disclosed |
| CN-115417972-A | Aromatic waterborne polyurethane resin and preparation method thereof | 安徽圣达生物药业有限公司 | 2022-12-02 | — | — | CN | disclosed |
| EP-0969056-A1 | Method for preparing an improved protein coating and articles thereof | Aventis Research & Technologies GmbH & Co KG (DE) | 2000-01-05 | — | — | EP | disclosed |
| WO-1999061538-A1 | METHOD FOR PREPARING A PROTEIN COATING AND ARTICLES THEREOF | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-12-02 | — | — | WO | disclosed |
| WO-1999061539-A1 | METHOD FOR PREPARING A PROTEIN COATING AND ARTICLES THEREOF | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-12-02 | — | — | WO | disclosed |
| EP-0960922-A1 | Method for preparing a protein coating and articles thereof | Aventis Research & Technologies GmbH & Co KG (DE) | 1999-12-01 | — | — | EP | disclosed |
| US-5753750-A | REACTION OF MONOALCOHOL WITH DIISOCYANATE AND DISSOLVING THE REACTION PRODUCT IN DIISOCYANATE OR POLYISOCYANATE TO FORM POLYURETHANE | BAYER CORPORATION (US) | 1998-05-19 | — | — | US | disclosed |
| US-5753749-A | Dicyclohexylmethane diisocyanate residue-based compositions and the use of such compositions as fillers | BAYER CORPORATION (US) | 1998-05-19 | — | — | US | disclosed |
| US-5539006-A | CLOSED CELL POLYURETHANE FORMED FROM POLYISOCYANATES, SUCROSE, ETHYLENE OXIDE AND PROPYLENE OXIDE POLYETHER, BLOWING AGENT AND CATALYST | BAYER CORPORATION (US) | 1996-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159571-A1 | SILYLATED ORGANOMODIFIED COMPOUNDS | SHBG, NR5A1, CYP19A1 | CA12 555/4885CA1 943/4885CA2 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.